D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus
placebo in relieving the signs and symptoms of patients with chronic lower back pain.